Ingevity (NGVT) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 were $376.9 million, down 16% year-over-year, mainly due to repositioning in Performance Chemicals and weather-related impacts on Road Technologies.

• The company reported a net loss of $107.2 million, driven by $86.9 million in restructuring charges, $100 million in contract termination fees, and a $349.1 million goodwill impairment in Performance Chemicals.

• Adjusted EBITDA was $106.4 million (28.2% margin), down 3.6% year-over-year, with gross margin up significantly due to mix shift and cost savings.

• Major restructuring included closure of Crossett and DeRidder facilities, workforce reductions, and exit from long-term CTO supply contracts.

• Performance Materials and Advanced Polymer Technologies segments delivered sales growth and margin improvements, while Performance Chemicals underwent significant repositioning.

Financial highlights

• Q3 2024 net sales: $376.9 million (down 16% year-over-year); net loss: $107.2 million; adjusted EBITDA: $106.4 million (28.2% margin); adjusted EPS: $1.10.

• Gross profit for Q3 2024 was $129.9 million, flat year-over-year, with gross margin up to 38.7%.

• Free cash flow was $28.5 million, including $50 million CTO contract payment and $21 million in restructuring charges.

• Net leverage ratio was 4.0x, expected to decline to 3.5x by year-end; cash and cash equivalents at quarter-end were $135.5 million.

• Capital expenditures for nine months were $52.7 million; projected 2024 CapEx: $90–$100 million.

Outlook and guidance

• Full-year 2024 sales expected between $1.40 billion and $1.50 billion, with adjusted EBITDA guidance of $350–$360 million.

• Performance Chemicals repositioning expected to yield $95–$110 million in annualized cash savings, with $65–$75 million realized in 2024.

• Priorities include improving execution, reducing leverage, and reviewing the business portfolio; targeting $400 million EBITDA and leverage around 3x by year-end 2025.

• Free cash flow expected to remain positive despite restructuring and contract termination payments.

• Key uncertainties include global industrial recovery, geopolitical risks, U.S. election dynamics, and auto production pace.